Michael Wolff Jensen
General Counsel at ASCENDIS PHARMA A/S
Net worth: 291 909 $ as of 2024-03-30
Network origin in Michael Wolff Jensen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 34 | |
18
| Public Company | Electric Utilities | 18 |
| Subsidiary | Pharmaceuticals: Major | 12 | |
VISEN Pharmaceuticals
 VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China.
11
| Private Company | Biotechnology | 11 |
11
| Public Company | Pharmaceuticals: Major | 11 |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
 VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction.
5
| Holding Company | Pharmaceuticals: Major | 5 |
| Public Company | Pharmaceuticals: Major | 4 | |
| Public Company | Pharmaceuticals: Major | 3 | |
Ascendis Pharma Endocrinology Division A/S
 Ascendis Pharma Endocrinology Division A/S Pharmaceuticals: MajorHealth Technology Ascendis Pharma Endocrinology Division A/S engages in pharmaceutical preparations. The company was founded on June 29, 2012 and is headquartered in Hellerup, Denmark.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Ascendis Pharma Bone Diseases A/S
1
| Subsidiary | 1 | |
Ascendis Pharma, Inc.
1
| Subsidiary | 1 | |
Ascendis Pharma Growth Disorders AS
1
| Subsidiary | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Wolff Jensen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal General Counsel | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| BERTELSMANN SE & CO. KGAA | Movies/Entertainment | Director/Board Member Director/Board Member | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal Chief Executive Officer | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Secretary Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Masters Business Admin | |
| VESTAS WIND SYSTEMS A/S | Electrical Products | Director/Board Member Corporate Officer/Principal | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal President | |
| CARLSBERG A/S | Beverages: Alcoholic | Corporate Officer/Principal Director/Board Member Chairman | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Chairman Chief Executive Officer | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | President Chairman Corporate Officer/Principal Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member | |
Carlsberg Breweries A/S
 Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Beverages: Alcoholic | Chairman Chairman | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree Graduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Masters Business Admin Graduate Degree | |
| University of Uppsala | College/University | Doctorate Degree Graduate Degree | |
| University of San Diego | College/University | Graduate Degree Masters Business Admin | |
| University of Aarhus | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| Technical University of Denmark | College/University | Doctorate Degree Director/Board Member Doctorate Degree | |
| University of Copenhagen | College/University | Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Leiden | College/University | Graduate Degree Doctorate Degree | |
| University of Utrecht | College/University | Doctorate Degree Doctorate Degree | |
| University of Southern Denmark | College/University | Undergraduate Degree Doctorate Degree | |
PricewaterhouseCoopers (Denmark)
 PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a private company based in Hellerup, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chairman | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| ASCENDANT RESOURCES INC. | Other Metals/Minerals | Chief Executive Officer Chief Operating Officer | |
| NUCANA PLC | Biotechnology | Director/Board Member Director/Board Member | |
Bertelsmann Management SE
 Bertelsmann Management SE Miscellaneous Commercial ServicesCommercial Services Bertelsmann Management SE is an international media enterprise with corporate divisions including RTL Group, Penguin Random House, and Gruner + Jahr. The private company is based in Gütersloh, DE and has a global presence of subsidiaries in several regions. The German company's Press Center provides detailed information for journalists, and the company is also committed to Corporate Responsibility activities. Thomas Hermann Rabe has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Director of Finance/CFO | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Copenhagen Infrastructure Partners P/S
 Copenhagen Infrastructure Partners P/S Investment ManagersFinance Copenhagen Infrastructure Partners P/S (CIP) is a private equity firm founded- in 2012 by Jakob Baruël Poulsen, Christian Skakkebæk, Torsten Lodberg Smed, and Rune Bro Róin. The firm is headquartered in Copenhagen, Denmark. | Investment Managers | Consultant / Advisor Founder Founder | |
| Y-MABS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| INNOCARE PHARMA LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member |
Statistics
International
| United States | 18 |
| Denmark | 16 |
| Sweden | 7 |
| Germany | 3 |
| United Kingdom | 3 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 16 |
| Commercial Services | 6 |
| Finance | 5 |
| Consumer Non-Durables | 3 |
Operational
| Director/Board Member | 461 |
| Corporate Officer/Principal | 188 |
| Chairman | 127 |
| Independent Dir/Board Member | 116 |
| Chief Executive Officer | 58 |
Most connected contacts
| Insiders | |
|---|---|
| James Healy | 50 |
| Carsten Krogsgaard Thomsen | 46 |
| Jonathan Silverstein | 42 |
| Henrik Poulsen | 37 |
| Albert Cha | 30 |
| Pierre Armand Morgon | 29 |
| Maha Katabi | 28 |
| Lars Holtug | 26 |
| Thomas Dyrberg | 24 |
| Jean Deleage | 23 |
| Rafaèle Elisabeth Tordjman | 23 |
| Sze Ting Chan | 23 |
| Lars Rebien Sørensen | 22 |
| Martin Olin | 22 |
| Hong Ni | 22 |
- Stock Market
- Insiders
- Michael Wolff Jensen
- Company connections
